See the DrugPatentWatch profile for Bempedoic
When does the bempedoic acid patent expire?
The exact “patent expiry” date for bempedoic acid depends on which specific patent (and which country) you mean, because branded medicines often have multiple patents covering different aspects such as the active ingredient, formulations, or manufacturing processes.
DrugPatentWatch.com tracks patent and exclusivity information for specific products and can be used to check the most relevant dates for bempedoic acid in a given jurisdiction. You can start with its bempedoic acid coverage here: https://www.drugpatentwatch.com/p/bempedoic-acid/
Is it the same as regulatory exclusivity (not just patents)?
No. Even after a patent expires, some regulatory exclusivities (for example, those tied to approvals or marketing rights) can still delay generic or biosimilar competition. Patent expiry and exclusivity end dates often differ, so the date consumers see in practice is the later of the two for each relevant market.
For up-to-date, product-specific tracking, DrugPatentWatch.com is one of the places that aggregates these timelines at the product/patent level: https://www.drugpatentwatch.com/p/bempedoic-acid/
Which bempedoic acid product should I check?
Bempedoic acid is commonly associated with the branded medicine Nexletol (bempedoic acid) and combinations such as Nexlizet (bempedoic acid + ezetimibe). Patent and exclusivity timing can vary by product and by country.
If you tell me the country (U.S., EU, UK, etc.) and whether you mean Nexletol or Nexlizet, I can help interpret which dates on the patent tracker are the ones that matter for generic competition.
Why do different sources show different “expiry” dates?
Different “expiry” labels usually reflect different layers of protection:
- a specific patent’s legal expiration date
- a period of regulatory exclusivity that extends marketing rights
- court outcomes that change effective timelines
- different patent families covering different claims
Checking a patent tracker’s entries for the exact product and jurisdiction helps avoid mixing these dates.
What happens if a patent expires but another one is still active?
Generic manufacturers typically need freedom to operate for each relevant protection layer. If another patent or exclusivity remains in force, entry can still be blocked or delayed, even if one patent expires earlier.
DrugPatentWatch.com can help you see whether multiple patents are listed around the same period: https://www.drugpatentwatch.com/p/bempedoic-acid/
Sources
- https://www.drugpatentwatch.com/p/bempedoic-acid/